Results

Total Results: over 10,000 records

Showing results for "tables".

  1. Tables 8-11 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%208-11.pdf
    June 02, 2025 - Tables 8-11 Table 8. … Table 9. … Table 10. … Table 11.
  2. Tables 1-7 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%201-7.pdf
    June 02, 2025 - Tables 1-7 Table 1. … Contingency Table for Presence of Chart Review Exclusions Senior Abstractor Identified Chart-Based … Contingency Table for Presence of Seizure in Administrative Claims and Charts Seizure in Claims … Table 3. … Table 4.
  3. Tables 11-14 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-section-7.pdf
    June 02, 2025 - Tables 11-14 Table 11. … Table 12. … Table 13. … Table 14.
  4. Tables 7-10 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-7-10.pdf
    June 02, 2025 - Tables 7-10 TABLE 7 Quantile Percent in Poverty Maximum 49.9% 99 37.5% 95 28.9% … 90 25.7% 75 20.7% 50 16.5% 25 12.5% 10 10.0% 5 8.6% 1 6.1% Minimum 2.9% TABLE 8 … TABLE 9 UIC_2013 UIC_2013 Frequency Percent 1 432 13.74 2 735 23.39 3 130 4.14 4 … 7 162 5.15 8 269 8.56 9 184 5.85 10 189 6.01 11 125 3.98 12 182 5.79 TABLE … 7 HROB Table 8
  5. Tables 2-5 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-2-5.pdf
    June 02, 2025 - Tables 2-5 … TABLE 2 High-risk … 35] 29% [25, 33] 0.01 Proportion funded by private insurance* 45% [25, 65] 35% [20, 70] 0.22 TABLETABLE … 1.4%) In-hospital coverage unnecessary 5 (6.3%) 1 (10%) 17 (28.8%) 89 (64.0%) TABLE
  6. Section 5, Tables (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-5-tables.pdf
    January 01, 2007 - Section 5, Tables Outcome Measure Restrictive strategy n (%) Liberal strategy n (%) P value … 22.2%) 118 (28.1%) 0.05 Multiple organ dysfunction adjusted score 10.7±7.5 11.8±7.7 0.03 Table … (3%) 8 (3%) 0.50 28-day mortality 14 (4%) 14 (4%) 0.98 New MODS 38 (12%) 39 (12%) NI Table … days 6.0 ± 5.4 days 0.76 ICU stay after randomization 9.5 ± 7.9 days 9.9 ± 7.4 days 0.39 Table
  7. Tables 7-10 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-section-6.pdf
    January 01, 2006 - Tables 7-10 Table 7: Ratio of All MRI to All CT Scans within 30 days of Evaluation for Atraumatic Headache … Table 8. … 4990 17466 0.99 Texas 7755 28147 1.00 Utah 332 988 0.90 Median (range) 0.99 (0.90-1.00) Table … 9: Contingency Table for Presence of Exclusions in Administrative Claims and Charts for Children with … 10: Contingency Table for Presence of Exclusions in Administrative Claims and Charts for Children with
  8. Tables 1-7 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chirpa-215-scd-ed-tables.pdf
    January 01, 2002 - Tables 1-7 Table 1: Codes to Identify Sickle Cell Disease Name Hemoglobin Screening Result ICD‐9 Code … SD‐disease Hb F,S,D 282.68, 282.69 Hb SS‐disease (sickle cell anemia) Hb F,S 282.61, 282.62 TableTable 3. … Table 5. … Table 6.
  9. IC Tables (pdf file)

    meps.ahrq.gov/data_stats/summ_tables/insr/state/series_10/2021/ic21_xc_e.pdf
    January 01, 2021 - IC Tables Table X.C Premium distributions (in dollars) for private-sector employees enrolled in single … Table X.C Standard errors for premium distributions (in dollars) for private-sector employees enrolled … Table X.C.1 Employee contribution distributions (in dollars) for private-sector employees enrolled in … Table X.C.2 Employer cost distributions (in dollars) for private-sector employees enrolled in single … IC Tables Table X.C Premium distributions (in dollars) for private-sector employees enrolled in single
  10. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-section-6-b.pdf
    June 02, 2025 - Section 6.B, Validity Tables … Validity - Tables Table 1. … 5.15% CA 7.70% 11.88% MI 8.05% 1.93% KS 9.44% 16.36% Total 6.64% 9.81% Correlation 0.00758 Table
  11. hcup-us.ahrq.gov/reports/trendtables/summarytrendtables.jsp
    May 01, 2025 - HCUP Summary Trend Tables … The HCUP Summary Trend Tables include downloadable Microsoft® Excel tables with information on the following … Graphs from HCUP Summary Trend Tables A focused report with graphs derived from Table 2d displays the … HCUP Summary Trend Tables The following is a list of the available HCUP Summary Trend Tables. … Internet Citation: HCUP Summary Trend Tables.
  12. Section 3-A, Tables (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-3-a-tables.pdf
    June 02, 2025 - Section 3-A, Tables Outcome Transfused Not transfused P value Patients 131 109 Average entry … 8.6 ± 9.8 days 5.7 ± 7.6 days < 0.001 Hospital LOS 18.9 ± 17.6 days 12.4 ± 10.5 days < 0.001 Table … days days days 1.32 days days Significance p<0.0012 P<0.0003 p=0.0047 P=0.0009 P=0.0012 Table
  13. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-6-table-9.pdf
    June 02, 2025 - Section 6, Tables 7-9 Table 9: Documentation of Heart Rate for Children with Severe Sepsis or Septic
  14. IC Tables - 6 (pdf file)

    meps.ahrq.gov/data_stats/summ_tables/insr/state/series_9/2021/ic21_ixa_e.pdf
    January 01, 2021 - IC Tables - 6 Table IX.A.1 Health insurance offer, eligibility and take up rates for private-sector … Table IX.A.1 Standard errors for health insurance offer, eligibility, take up rates for private-sector … Table IX.A.3 Health insurance offer, eligibility and take up rates for private-sector establishments … Table IX.B.1 Health insurance offer, eligibility and take up rates for private-sector establishments … Table IX Table IX.A.1 Health insurance offer, eligibility and take up rates for private-sector establishments
  15. effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.pdf
    May 29, 2025 - 1 Table 1. … Digestive and Urinary Neoplasms 13 Other Neoplasms 14 Benign Neoplasms of Skin, Breast, Eye 7 Table … Monoclonal antibodies Trastuzumab 12 months 88.4 9.0 2.0 2.2 10.9 0.5 1.4 4.5 5.5 11 Table … Kinase inhibitors Trastuzumab American Indian/Alaska Native 0.3 * * * 0.0 * * * * 28 Table
  16. effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.xls
    May 29, 2025 - OT.1 Table 1. … Digestive and Urinary Neoplasms 13 Other Neoplasms 14 Benign Neoplasms of Skin, Breast, Eye OT.3 Table … Antibodies TRASTUZUMAB 12 months 88.44% 8.99% 2.03% 2.23% 10.95% 0.46% 1.44% 4.45% 5.49% OT.4 Table … 0.1% Kinase Inhibitors TRASTUZUMAB American Indian/Alaska Native 0.3% - - - 0.0% - - - - OT.5 Table
  17. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-tables-8-11.pdf
    June 02, 2025 - CHIPRA 207: Tables 8-11 … Tables … 8a-e: Risk Model Estimates using Adjusted Model Table 8a. … Tables … 11: Correlation with Complication Rates Table 11.
  18. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
    June 02, 2025 - Section 1, Tables 1-4 1 Table 1: Definition of Severe Sepsis and Septic Shock Term Definition … times upper limit of normal for age Septic Shock Sepsis and cardiovascular organ dysfunction 3 Table … Severe Sepsis or Septic Shock For children who are not hypotensive: resolution of tachycardia (see Table … For children who are hypotensive: resolution of hypotension (see Table 4) PLUS resolution of any 1 … • Tachycardia (see Table 4) 4 Table 4: Age-Specific Vital Signs and Laboratory Variables Age
  19. hcup-us.ahrq.gov/reports/methods/MS-2021-04-Appendix.xlsx
    January 01, 2021 - Appendix A Data Tables Title Page 26-Aug-15 HCUP METHODS SERIES REPORT 2021-04 … Census Bureau, https://www.census.gov/data/tables/2017/demo/popest/nation-total.html. … Census Bureau, https://www.census.gov/data/tables/2016/demo/popest/nation-total.html. … http://www.census.gov/popest/data/state/totals/2013/tables/NST-EST2013-01.xls. … Table A.6 Table A.6 Annual Estimates of the U.S.
  20. effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_tables.xlsx
    January 01, 2009 - 1. Antidiab Prevalence of Drugs by Antidiabetic Class, Among Medicare Parts A, B, and D FFS Population With Diabetes, by Age, Gender, and Race, 2006-2009 Age is calculated as of December 31 of the year. Note: A dash signifies small cell count (<11). Breakdown Category Year Alpha Glucosidase Inhibitors Amylin A…